Navigation Links
InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom
Date:9/17/2007

UK's Largest Pharmacy Distributor Introduces RESPeRATE Hypertension

Treatment Device Into Country's Retail Market

NEW YORK and LONDON, Sept. 17 /PRNewswire/ -- InterCure, Ltd. (TASE: INCR), today announced that its RESPeRATE(R) hypertension treatment device, clinically-proven in 10 peer-reviewed studies to significantly lower blood pressure, will launch into retail distribution in the United Kingdom through Mashco, Ltd., the country's largest distributor of healthcare diagnostics to the independent pharmacy market. The partnership marks a milestone for RESPeRATE, which has previously been sold directly to consumers through its website, http://www.resperate.com and through online resellers such as Amazon.com.

According to the terms of the agreement, Mashco will initially introduce RESPeRATE into 100 of its key retail partner locations beginning this month, with an emphasis on prominent stores which offer diagnostic blood pressure testing. Mashco will provide pharmacist education, patient information and an assortment of merchandising programs to introduce RESPeRATE as a valuable addition to patients' hypertension management regimens. In-store marketing will highlight the importance of combining diagnostic and therapeutic solutions to best manage hypertension under the guidance of a physician and pharmacist. Full rollout of RESPeRATE into the independent pharmacy market in the UK will occur immediately following the 100-store launch. Mashco currently serves 3,000 pharmacies in the United Kingdom.

"RESPeRATE's tremendous growth has been fueled by the massive numbers of frustrated hypertension sufferers who seek our safe, efficacious, non-drug treatment option," said Erez Gavish, president and CEO of InterCure. "Yet, two-thirds of our prospective customers tell us that they would prefer to buy RESPeRATE through their local pharmacy. InterCure's move into the UK independent ph
'/>"/>

SOURCE InterCure, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle, WARF announce partnership to lure stem cell companies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., N.C., Nov. 25 Research Triangle ...fficient, single-treatment water purification syst... Andhra Pradesh, Minister of Rural Water Supply, H...ad, India today. Initial tests, performed at India...that the majority of the drinking water available ...
(Date:11/25/2009)..., ,, BOCA RATON, Fla., Nov. 25 /PRNewswir... year. Not so for BodyLogicMD. The nation,s large...s specializing exclusively in medically supervised... physicians in its network since November 200... to add more physician-owned centers, including on...
(Date:11/25/2009)...RK, Nov. 25 Reportlinker.com annou...e in its catalogue: ,, Brazil Bioethanol Marke...w.reportlinker.com/p0165503/Brazil-Bioethanol-Mark...il Bioethanol Market Analysis and Forecasts to 201...ed analysis and forecasts of the global bioethanol...
(Date:11/24/2009)... Nov. 24 IES (Nasdaq: I...nd communications systems and services for the com...nced today that its commercial business group has ...o install the electrical systems for the Level 4 b...U.S. Army Medical Research Institute of Infectious...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
... February 24 , - Syndicate Comprises Leading ... Partners and Novartis Option Fund , Heptares ...ed on drugs,targeting G-protein-coupled receptors ...on (US$30 million) of equity finance in a successf...ernational venture capital firms.,Clarus Ventures ...
...RINGS, Colo., Feb. 23 The National Academy of Sci...ed on February 18, 2009 finds deficiencies in the ...or reforms and new research. The report also call...guidelines for quality control, proficiency testin...in all aspects of forensic science. , , The repor...
...only event brings together healthcare C-suite lead...enges and opportunities of integrating technology ... , , NEW YORK, Feb. 23 Healthcare Infor m ati...y on servicing acute-care C-suite IT leaders, and ...search, education, and advocacy organization, are ...
Other Biology Technology:Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 2Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 3Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 4Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 5Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations 2Healthcare Executives Will Discuss How Best to Spend Economic Stimulus Money at June Conference 2Healthcare Executives Will Discuss How Best to Spend Economic Stimulus Money at June Conference 3
(Date:11/30/2009)...ht the stress of seeing your extended family over ... research report in the December 2009 print issue ....jleukbio.org ) shows that you might be right. Her...ht lead to entirely new treatments that help keep ...ema under control. That,s because researchers from...
(Date:11/26/2009)... are some of the Ocean,s most distinctive resident...s strange head shape, says Michelle McComb from F... the shark,s vision. ,Perhaps their visual field h...McComb, giving the sharks excellent stereovision a... there were two schools of thought on this theory....
(Date:11/26/2009)...(November 26, 2009) Whitehead researchers have de...ls to pinpoint specific genes and proteins used by... , In most human cell cultures genes are present...one from the mother. Gene inactivation by mutation... inactivated, the second copy usually remains acti...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Wide heads give hammerheads exceptional stereo view 2Knockouts in human cells point to pathogenic targets 2TrinityCare Senior Living Announces Expansion into Louisiana 57948 1TrinityCare Senior Living Announces Expansion into Louisiana 57948 2TrinityCare Senior Living Announces Expansion into Louisiana 57948 3DUSA Pharmaceuticals to Present at the Maxim Group 3rd Annual Growth Conference 57945 1New and Interesting PROSTVAC 28TM 29 Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer 14203 1New and Interesting PROSTVAC 28TM 29 Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer 14203 2New and Interesting PROSTVAC 28TM 29 Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer 14203 3
...he study was initiated in 1985. A total of 51 teen... with an equally large control group of healthy pe...red several times as the years have passed. , "Thi... It is the only study in the world that reflects t...ation", says Elisabet Wentz, Associate Professor i...
...ike doctors making house calls, some DNA repair en...eds their help, a collaborative team of scientists... , The signal that prompts relocation is oxidativ...ected with several human diseases. , The study i...resulted in a new level of understanding of the ce...
...This release is available in German . , Helsin...ange, such as emissions trading, will only be succ...overnment policies addressing economic and social ...ership for European Environmental Research (PEER)....st European environmental research institutes. , ...
Other Biology News:Psychiatric disorders are common in adults who have had anorexia 2DNA repair mechanisms relocate in response to stress 2Climate change aims need to be better integrated 2
Stand for Multichannel Pipettes from Thermo Scientific
...lynucleotide Kinase (PNK) catalyzes the transfer o...of single- and double-stranded DNA, RNA, and nucle...he 3'-phosphate from 3'-phosphoryl polynucleotides...ribonucleoside 3', 5'-diphosphates to form a 3'-hy...
T3 RNA Polymerase from Roche Applied Science
Maxi 14 Hybridization Oven from Thermo Scientific
Biology Products: